H.A.R.T Spotlight


H.A.R.T, Helping the Body Heal Itself

Harvard Apparatus Regenerative Technology, (HART)  develops bio-engineered organs. It sounds like science fiction but it’s becoming a science reality. We’re focusing on restoring organ function for esophageal cancer, central lung cancer and life threatening conditions of the trachea.

Our technology uses the body’s own cells and a 3D scaffold to help the body heal itself. By using the patient’s own cells you avoid the potential of an immune response.

Our first generation product extended life by a year to two years with patients that were originally diagnosed with a month to live.

We’re participating across billion dollar markets and we will look to file with the FDA in 2016 for our first of hopefully many indications.

Request Investor Kit



Phone Number*